Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial

NCT07681167 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Central Serous Chorioretinopathy (CSC)

Interventions

DRUG: Faricimab
DRUG: Sham

Sponsor

Singapore National Eye Centre

Collaborators

[object Object]